USPTO serial 76608648
Reviewed by CopyMark Law Group
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $1,300
Dundee DD2 1NH, GB
Dundee DD2 1TY, GB
Dundee DD2 1TY, GB
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michele M. Glessner
Michele M. Glessner Alston & Bird LLP101 South Tryon Street, Suite 4000Charlotte, NC 28280-4000UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 001 | BIOCHEMICAL PREPARATIONS, NAMELY, MONOCLONAL ANTIBODIES FOR IN VITRO SCIENTIFIC OR RESEARCH USE, POLYCLONAL ANTIBODIES FOR IN VITRO SCIENTIFIC OR RESEARCH USE, RECOMBINANT PROTEIN, ENZYMES, RECOMBINANT HUMAN ENZYMES, RECOMBINANT HUMAN ENZYMES IN BACTERIA, RECOMBINANT HUMAN DRUG-METABOLIZING ENZYMES, METABOLITES, ALL FOR SCIENTIFIC OR RESEARCH USE; REAGENTS FOR USE IN DEVELOPMENT OF POLYCLONAL ANTIBODIES FOR SCIENTIFIC OR RESEARCH USE; BACTERIAL PREPARATIONS FOR SCIENTIFIC OR RESEARCH USE; ASSAYS FOR SCIENTIFIC OR RESEARCH USE | ACTIVE | — |
| 005 | [BIOCHEMICAL PREPARATIONS FOR MEDICAL OR VETERINARY USE, NAMELY, MONOCLONAL ANTIBODIES, POLYCLONAL ANTIBODIES, TAGGED ANTIBODIES, RECOMBINANT PROTEIN, ENZYMES, RECOMBINANT HUMAN ENZYMES, RECOMBINANT HUMAN ENZYMES IN BACTERIA, RECOMBINANT HUMAN DRUG-METABOLIZING ENZYMES; REAGENTS FOR USE IN DEVELOPMENT OF MONOCLONAL ANTIBODIES FOR MEDICAL USE; REAGENTS FOR USE IN DEVELOPMENT OF POLYCLONAL ANTIBODIES FOR MEDICAL USE; CHEMICAL PREPARATIONS CONTAINING ENZYMES FOR MEDICAL PURPOSES; CHEMICAL PREPARATIONS CONTAINING ENZYMES FOR PHARMACEUTICAL PURPOSES; ASSAYS FOR MEDICAL USE; BACTERIAL PRODUCTS, NAMELY, BACTERIAL CULTURES FOR MEDICAL USE; BACTERIAL PREPARATIONS FOR MEDICAL USE; BACTERIAL VACCINES FOR MEDICAL USE; BACTERIAL MEMBRANES FOR MEDICAL USE; REAGENTS IN KIT FORM FOR MEDICAL USE] | SECTION 8 - CANCELLED | — |
| 042 | SCIENTIFIC RESEARCH SERVICES IN THE FIELD OF BIOTECHNOLOGY, NAMELY, DRUG METABOLITE SYNTHESIS, HETEROLOGOUS PROTEIN EXPRESSION, IN VITRO DRUG METABOLISM SYSTEMS, PRODUCTION OF RECOMBINANT PROTEIN, PRODUCTION OF RECOMBINANT HUMAN ENZYMES, PRODUCTION OF RECOMBINANT HUMAN ENZYMES IN BACTERIA, PRODUCTION OF RECOMBINANT HUMAN DRUG-METABOLIZING ENZYMES; SCIENTIFIC RESEARCH CONSULTATION | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| May 1, 2026 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Apr 19, 2017 | NA89 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | — |
| Apr 19, 2017 | RNL1 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| Apr 19, 2017 | 89AG | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | The USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary. |
| Apr 18, 2017 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| May 1, 2016 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Aug 27, 2012 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Aug 26, 2012 | C15P | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Aug 26, 2012 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Aug 8, 2012 | 815F | REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED | — |
| Aug 8, 2012 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| May 1, 2007 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 13, 2007 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 24, 2007 | NPUB | NOTICE OF PUBLICATION | — |
| Dec 18, 2006 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 15, 2006 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 6, 2006 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Dec 4, 2006 | ALIE | ASSIGNED TO LIE | — |
| Nov 13, 2006 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 13, 2006 | PAPER RECEIVED | — | |
| May 12, 2006 | CNSI | INQUIRY AS TO SUSPENSION MAILED | — |
| May 12, 2006 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| May 11, 2006 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Oct 27, 2005 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Oct 27, 2005 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Oct 6, 2005 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Sep 28, 2005 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 28, 2005 | PAPER RECEIVED | — | |
| Aug 23, 2005 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 28, 2005 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 25, 2005 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 25, 2005 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 18, 2004 | PAPER RECEIVED | — | |
| Sep 3, 2004 | NWAP | NEW APPLICATION ENTERED | — |